Rare truncating variations and risk of schizophrenia: Whole-exome sequencing in three families with affected siblings and a three-stage follow-up study in a Japanese population
暂无分享,去创建一个
I. Sora | M. Ikeda | S. Okazaki | Yuichiro Watanabe | T. Sugai | J. Egawa | T. Someya | N. Iwata | A. Shimasaki | A. Hishimoto | A. Nunokawa | M. Shibuya | T. Muratake | Takeo Saito | Hirofumi Igeta | Emiko Inoue | Satoshi Hoya | N. Kaneko | Kenji Kondo | Ayu Shimasaki
[1] Yuichiro Watanabe,et al. Whole-exome sequencing in a family with a monozygotic twin pair concordant for autism spectrum disorder and a follow-up study , 2015, Psychiatry Research.
[2] Yuichiro Watanabe,et al. Rare heterozygous truncating variations and risk of autism spectrum disorder: Whole‐exome sequencing of a multiplex family and follow‐up study in a Japanese population , 2015, Psychiatry and clinical neurosciences.
[3] Hongbing Shen,et al. Low-frequency coding variants at 6p21.33 and 20q11.21 are associated with lung cancer risk in Chinese populations. , 2015, American journal of human genetics.
[4] Yuichiro Watanabe,et al. Novel Rare Missense Variations and Risk of Autism Spectrum Disorder: Whole-Exome Sequencing in Two Families with Affected Siblings and a Two-Stage Follow-Up Study in a Japanese Population , 2015, PloS one.
[5] Tadafumi Kato,et al. Whole genome/exome sequencing in mood and psychotic disorders , 2015, Psychiatry and clinical neurosciences.
[6] D. Rujescu,et al. Exome Sequencing in 53 Sporadic Cases of Schizophrenia Identifies 18 Putative Candidate Genes , 2014, PloS one.
[7] A. J. Robison,et al. Emerging role of CaMKII in neuropsychiatric disease , 2014, Trends in Neurosciences.
[8] T. Tu,et al. Generation and Behavior Characterization of CaMKIIβ Knockout Mice , 2014, PloS one.
[9] C. Spencer,et al. Biological Insights From 108 Schizophrenia-Associated Genetic Loci , 2014, Nature.
[10] Peter M Visscher,et al. Large-scale genomics unveils the genetic architecture of psychiatric disorders , 2014, Nature Neuroscience.
[11] I. Ionita-Laza,et al. Loss-of-Function Variants in Schizophrenia Risk and SETD1A as a Candidate Susceptibility Gene , 2014, Neuron.
[12] Seungtai Yoon,et al. De novo Mutations in Schizophrenia Implicate Chromatin Remodeling and Support a Genetic Overlap with Autism and Intellectual Disability , 2014, Molecular Psychiatry.
[13] I. Sora,et al. Association analysis of putative cis-acting polymorphisms of interleukin-19 gene with schizophrenia , 2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[14] John Calvin Reed,et al. The NLR-related protein NWD1 is associated with prostate cancer and modulates androgen receptor signaling , 2014, Oncotarget.
[15] J. Hell,et al. CaMKII: Claiming Center Stage in Postsynaptic Function and Organization , 2014, Neuron.
[16] E. Banks,et al. De novo mutations in schizophrenia implicate synaptic networks , 2014, Nature.
[17] Erick R. Scott,et al. Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer’s disease , 2013, Nature.
[18] L. Siever,et al. Spatial and Temporal Mapping of De Novo Mutations in Schizophrenia to a Fetal Prefrontal Cortical Network , 2013, Cell.
[19] K. Matsuo,et al. Genetic evidence for association between NOTCH4 and schizophrenia supported by a GWAS follow-up study in a Japanese population , 2013, Molecular Psychiatry.
[20] Carl Baker,et al. Support for the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia from exome sequencing in multiplex families. , 2013, JAMA psychiatry.
[21] S. Levy,et al. De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia , 2012, Nature Genetics.
[22] Jianxin Shi,et al. Genome-wide association study of multiplex schizophrenia pedigrees. , 2012, The American journal of psychiatry.
[23] S. Lok,et al. Increased exonic de novo mutation rate in individuals with schizophrenia , 2011, Nature Genetics.
[24] Nils Z. Borgesius,et al. βCaMKII Plays a Nonenzymatic Role in Hippocampal Synaptic Plasticity and Learning by Targeting αCaMKII to Synapses , 2011, The Journal of Neuroscience.
[25] Fan Yang,et al. Two-Stage Design of Sequencing Studies for Testing Association with Rare Variants , 2011, Human Heredity.
[26] N. Craddock,et al. Genome-Wide Association Study of Schizophrenia in a Japanese Population , 2011, Biological Psychiatry.
[27] D. Goldstein,et al. Uncovering the roles of rare variants in common disease through whole-genome sequencing , 2010, Nature Reviews Genetics.
[28] Y. Kamatani,et al. A genome-wide association study in 19 633 Japanese subjects identified LHX3-QSOX2 and IGF1 as adult height loci. , 2010, Human Molecular Genetics.
[29] M. Itokawa,et al. The dopamine D3 receptor (DRD3) gene and risk of schizophrenia: Case–control studies and an updated meta-analysis , 2010, Schizophrenia Research.
[30] C. Hansel,et al. βCaMKII controls the direction of plasticity at parallel fiber–Purkinje cell synapses , 2009, Nature Neuroscience.
[31] Yuichiro Watanabe,et al. No association between the brain-derived neurotrophic factor gene and schizophrenia in a Japanese population , 2006, Schizophrenia Research.
[32] P. Seeman,et al. Increased expression of calcium/calmodulin‐dependent protein kinase IIβ in frontal cortex in schizophrenia and depression , 2006, Synapse.
[33] Naoshi Kaneko,et al. Genomewide high-density SNP linkage analysis of 236 Japanese families supports the existence of schizophrenia susceptibility loci on chromosomes 1p, 14q, and 20p. , 2005, American journal of human genetics.
[34] J. Bertin,et al. Inhibition of Bcl10‐mediated activation of NF‐κB by BinCARD, a Bcl10‐interacting CARD protein , 2004 .
[35] H. Takeuchi,et al. Identification and characterization of Mlr1,2: two mouse homologues of Mblk‐1, a transcription factor from the honeybee brain , 2003 .